St. Jude Gets Japanese Approval for Heart Failure Treatment Products
July 17, 2007 - St. Jude Medical Inc. today announced that it received regulatory approval from the Japanese Ministry of Health, Labor and Welfare and reimbursement approval for its first CRT-D systems to be marketed in Japan.
The two new systems used to treat heart failure patients have been approved, including the Atlas HF CRT-D (cardiac resynchronization therapy defibrillator) and the Epic HF CRT-D, which are used in conjunction with the QuickSite left-heart lead and delivered through the Apeel CS catheter delivery system.
The Atlas HF CRT-D reportedly delivers high output and tailored waveforms for patients with hearts that are difficult to defibrillate. The Epic HF CRT-D is designed for improved patient comfort.
For more information: www.sjm.com
More like this
- St. Jude Launches QuickOpt Timing Cycle Optimization for Defibrillators in Japan
- First U.S. CRT Device with A-Fib Feature
- St Jude Receives FDA Clearance for First U.S. CRT Device with A-Fib Feature
- SJM’s Radiofrequency ICD Features Wireless Communication
- Added Security for Difficult-to-Defibrillate Hearts Available